Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
RADD Capital appears to be a private investment and advisory firm rather than an operating life sciences, biotech, pharma, or healthcare company. Publicly available references describe it as a finance group involved in capital raising, private financings, and IPO-related advisory work, with activity concentrated in cannabis and adjacent consumer health or wellness businesses. Sources indicate the firm has advised or invested in companies such as HempFusion and has been associated with cannabis-sector financings in Canada. There is no evidence that RADD Capital itself develops therapeutic products, maintains a drug pipeline, or operates as a biotech platform company.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on RADD Capital.